American Association for the Advancement of Science, Science Translational Medicine, 623(13), 2021
DOI: 10.1126/scitranslmed.abf7036
Full text: Unavailable
Inhibiting LSD1 reduces glioblastoma tumor-initiating cell survival by impeding their ability to handle the stress through the deregulation of ATF4.